Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

THOR is a targetable epigenetic biomarker with clinical implications in breast cancer

1 Dec 2022

Abstract excerpt

BACKGROUND: Breast cancer (BC) is the most frequently diagnosed cancer and a leading cause of death among women worldwide. Early BC is potentially curable, but the mortality rates still observed among BC patients demonstrate the urgent need of novel and more effective diagnostic and therapeutic options. Limitless self-renewal is a hallmark of cancer, governed by telomere maintenance. In around 95% of BC cases,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Genomics and Chromatin Dynamics
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36529814
DOI: 10.1186/s13148-022-01396-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

THOR is a targetable epigenetic biomarker with clinical implications in breast cancerPMID 36529814Read ↗

Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancerSemantic proximity Read ↗

Recent Insights Into Breast Cancer: Molecular Pathways, Epigenetic Regulation, and Emerging Targeted TherapiesSemantic proximity Read ↗

DNA hypermethylation within TERT promoter upregulates TERT expression in cancerSemantic proximity Read ↗

TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic TargetsSemantic proximity Read ↗

DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?Semantic proximity Read ↗

Epigenetic reprogramming in breast cancer: from new targets to new therapies.Semantic proximity Read ↗

Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cellsSemantic proximity Read ↗

Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic ResponseSemantic proximity Read ↗

Epigenetic inactivation of DNA repair in breast cancer.Semantic proximity Read ↗

Methylome analysis reveals dysregulated developmental and viral pathways in breast cancerSemantic proximity Read ↗

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers.Semantic proximity Read ↗

Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.